An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype

Although clinical features, cytogenetics, and mutations are widely used to predict prognosis in patients with acute myeloid leukemia (AML), further refinement of risk stratification is necessary for optimal treatment, especially in cytogenetically normal (CN) patients. We sought to generate a simple...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Chuang, Ming-Kai, Chiu, Yu-Chiao, Chou, Wen-Chien, Hou, Hsin-An, Tseng, Mei-Hsuan, Kuo, Yi-Yi, Chen, Yidong, Chuang, Eric Y., Tien, Hwei-Fang
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2015
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4770759/
https://ncbi.nlm.nih.gov/pubmed/26517675
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares